Use of intravenous tissue plasminogen activator in a 16-year-old patient with basilar occlusion.

Abstract excerpt

Intravenous tissue plasminogen activator (t-PA) is currently approved by the US Food and Drug Administration (FDA) for the treatment of ischemic stroke in patients > 18 years of age who present within 3 hours of stroke onset and meet certain criteria. We report a case of a 16-year-old, previously healthy female who presented with a basilar artery occlusion and pontine ischemic stroke. She was treated with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Coagulation Disorders, Inherited
• Share to Crohn Disease